Infusion of menadione at two different doses [2.7 mg and 5.5 mg in 100 ,dl of dimethyl sulphoxide (DMSO)] into perfused rat livers for 30 min caused no or a 6-fold increase respectively in junctional permeability to horseradish peroxidase as compared with controls receiving 100 ul of DMSO alone. The total glutathione (GSH) contents in these livers measured at the end of the experiments were 115 % and 53 %, compared with the controls. The free-radical scavenger butylated hydroxytoluene (BHT) (final concn. 5/uM) protected against the GSH depletion caused by the higher dose of menadione and partially decreased the menadione-induced increase in junctional permeability. Verapamil, a Ca2+-channel blocker which was added into the perfusion medium (final concn. 40 1uM) 10 min before the infusion of 5.5 mg of menadione, completely abolished the effect of menadione on junctional permeability. Menadione exposure therefore increases tightjunctional permeability in the liver; this may involve a depletion of GSH and a subsequent increase in intracellular Ca2+.
INTRODUCTION
Tight-junctional permeability in the liver can be increased by a number of compounds (vasopressin, adrenalin, angiotensin) which, by stimulating the generation of inositol phosphates, result in an increase in intracellular [Ca2+] (Lowe et al., 1988) . The Ca2+ ionophore A23187, which increases the movement of Ca2+ across the plasma membrane and the membranes of intracellular organelles, has also been shown to increase tightjunctional permeability in the isolated perfused rat liver (Kan & Coleman, 1988) .
Several hepatotoxic compounds, e.g. menadione (Monte et al., 1984; Orrenius et al., 1988) , are thought to mediate their cellular effects ultimately via disturbances of intracellular Ca2+ homoeostasis. Whether such compounds influence tightjunctional permeability has yet to be explored.
Menadione is reduced in the liver to a semiquinone radical and, in the presence ofoxygen, it is reoxidized back to menadione; this redox cycling continuously generates superoxide anion, which is rapidly removed by the glutathione peroxidase system, leading to the formation of GSSG. This substantial loss of total GSH in the liver during menadione metabolism may ultimately lead to an increase in intracellular Ca2+, probably as a consequence of damage to the thiol proteins involved in gating the Ca2+ channels (see Monte et al., 1984) .
The present study examines the consequences to hepatic tightjunctional permeability of exposure of the liver to menadione, and also investigates the effects of menadione on junctional permeability in the presence of a free-radical scavenger (butylated hydroxytoluene) to prevent glutathione depletion, and of a Ca2+_ channel blocker (verapamil 
Liver perfusion
Male Wistar rats (approx. 250 g body wt. each) were used throughout the study. The bile duct was cannulated with PP 10 tubing during pentobarbital anaesthesia. The liver was isolated in situ as described by Hems et al. (1966) and perfused with 150 ml ofKrebs-Ringer bicarbonate solution (Krebs & Henseleit, 1932) containing 1 % (w/v) BSA, 5 mM-glucose, 1.2 mM-CaCI2, a physiological amino acid mixture (see Barnwell et al., 1983) and 20 % (v/v) packed ox red cells. The solution was continuously gassed with 02/CO2 (19:1) and was maintained at 37°C in a thermostatically controlled cabinet.
Menadione infusion
This was carried out at 10 min after initial liver perfusion; 100 pA of DMSO containing 0, 2.7 mg or 5.5 mg of menadione was infused into the liver via the portal line for a period of 30 min.
Drug pretreatments (i) BHT, dissolved in 10,l of DMSO, was added to the perfusion medium to give a final concentration of 5 ,M, 5 min before the infusion of menadione (5.5 mg in 100 ,l of DMSO) or DMSO (100 pl) alone. (ii) Verapamil, dissolved in 0.5 ml of 0.9 % NaCI, was added to the perfusion medium to give a final concentration of 40 1uM, 10 min before the infusion of 5.5 mg of menadione (dissolved in 100 ,l of DMSO).
HRP pulsing
At the end of the exposure period to menadione or DMSO (controls), the liver perfusion was converted to a single-pass condition, and 3 mg or HRP, dissolved in 1 ml of Krebs-Ringer bicarbonate solution, was then infused, within 1 min, into the livers at the same portal infusion point (Kan & Coleman, 1988) . At the end of 5 min as a single-pass perfusion, the liver was converted back to recycling perfusion for the rest of the experiment.
Vol. 270 Bile was collected into pre-weighed tubes, and the flow rates were determined gravimetrically (assuming a density of 1 g/ml). The HRP in the collected bile was assayed spectrophotometrically as described by Gallati & Pract (1975) . At the end of the experiment, a sample of the perfusion fluid was taken for the measurement of aspartate aminotransferase by a commercial assay kit; in all cases the amount of aminotransferase in the perfusion fluid was scarcely detectable, amounting only to less than 0.0 14 % of the liver activity.
Liver analysis
At the end of each perfusion, the liver was removed, weighed, and homogenized in 50 ml of Krebs-Ringer bicarbonate solution. The homogenate was deproteinized in 4% (w/v) HCI04 and centrifuged at 10000 g min; the acid-soluble glutathione in the supernatant was then measured by reaction with 5,5'-dithiobis-(2-nitrobenzoate) (Tietze, 1969) .
RESULTS AND DISCUSSION
Under single-pass perfusion conditions, an increase in the first peak height of biliary HRP correlates with an increase in junctional permeability (Lowe et al., 1985; Kan & Coleman, 1986 Kan et al., 1989) ; this peak height is therefore used in the present series of experiments as an indicator of junctional permeability change. In all cases of treatment described below, the biliary HRP peak occurred at 5 min and the bile-flow rates were all comparable (Table 1) .
When 2.7 mg of menadione was infused into the liver no increase in HRP peak height was observed compared with the control (Table 1 , rows a and b) whereas infusion of a higher dose (5.5 mg) significantly increased HRP peak height by 6-fold (Table  1 , rows a and c), suggesting an increase in junctional permeability as a consequence of exposure to the higher dose. Monte et al. (1984) have demonstrated that menadione causes a decrease in the total amount of cytosolic GSH in the isolated hepatocytes, and therefore GSH content was measured in the livers used above ( Table 2 ). The GSH content of livers exposed to the lower dose of menadione was similar to that of the control (DMSO), but those exposed to the higher dose of menadione, and which showed enhanced junctional permeability, had a substantial decrease in GSH content (to 53 % of the control).
Clearly, the lower dose of menadione did not overcome the ability of the liver to regenerate GSH, but had done so at the higher dose.
BHT pretreatment, which protected against menadioneinduced GSH loss and restored GSH values to those of controls (Table 2) , also decreased the effect of menadione on junctional permeability (Table 1) . However, the decrease in junctional permeability is not complete, even though the GSH content is fully restored. There are two possibilities for this: (i) the increase in junctional permeability caused by menadione is not solely due to a decrease in cytosolic GSH, but may include a further effect of menadione or its metabolites on junctions; (ii) the residual increase in permeability after BHT/menadione may be due to a complete abolition of the menadione effect, but BHT itself may have been responsible for the 2-fold increase in peak height; in this connection, studies by Billington et al. (1990) have demonstrated that higher doses of BHT cause substantial increase in junctional permeability in intact animals.
In other studies (Lowe et al., 1988; Kan & Coleman, 1988) , an increase in intracellular [Ca2+] has been suggested to lead to an increase in hepatic junctional permeability. The complete prevention of the 6-fold increase in junctional permeability by the Ca2+ blocker verapamil (Table 1 , rows c and e) indicated that the effect of menadione on junctional permeability may also involve an increase in intracellular [Ca2+] and that this increase can therefore be prevented by blocking the [Ca2+] elevation.
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